**Senator Todd Young Discusses Biosecurity and the National Security Commission on Emerging Biotechnology (NSCEB)** In recent years, the intersection of...

# Utilizing the Body’s Natural Protein Degradation System for Disease Treatment – Insights from the Beyond Biotech Podcast by Labiotech...

**Laverock Therapeutics: Expanding Gene-Silencing Technology to Address Multiple Disease Areas** In recent years, the field of gene therapy has witnessed...

**FDA Approves Bristol Myers’ Groundbreaking Schizophrenia Drug, a First-of-Its-Kind Treatment** In a significant advancement for the treatment of schizophrenia, the...

**BioAge Labs Aims to Raise $198M Through Expanded IPO to Fund Obesity Clinical Trials** *Introduction* BioAge Labs, a biotechnology company...

**BioAge Labs Aims to Combat Obesity with $198M IPO to Support Clinical Trials Expansion** In recent years, the global obesity...

**BioAge Labs Plans $198M IPO to Fund Clinical Trials for Obesity Treatment** *Introduction* BioAge Labs, a biotechnology company focused on...

**Pfizer to Discontinue Sickle Cell Drug and Halt Ongoing Clinical Trials: What You Need to Know** In a surprising development,...

# Top 10 Emerging Biotech Startups in Europe to Watch in 2024 The biotechnology sector in Europe is experiencing a...

**ETCh Study by Etcembly Identifies New Cancer Targets from Survivor Data** In the ever-evolving field of cancer research, the identification...

# ESMO Update: AstraZeneca Achieves Success in Bladder Cancer Treatment and Other Key Developments The European Society for Medical Oncology...

# In Vivo Validation of a Fully Implantable, Custom-Designed Cochlear Implant System Using an Animal Model – Communications Engineering ##...

**Population Control in *Drosophila* via Release of Insects with a Dominant Sterile Gene Drive Targeting the *doublesex* Gene – Nature...

# In Vivo Validation of a Fully Implantable Full-Custom Cochlear Implant System Using an Animal Model – Communications Engineering ##...

**The Potential Role of GLP-1 Drugs in Managing Type 1 Diabetes** Type 1 diabetes (T1D) is a chronic autoimmune condition...

# Comprehensive Guide to Stealth Mode Biotech Startups: Key Insights and Information In the fast-paced world of biotechnology, innovation is...

# Comprehensive Guide to Stealth Mode Biotech Startups: Key Insights and Information In the fast-paced world of biotechnology, innovation is...

**Exploring the Combined Impact of AI and Synthetic Biology: Insights from S&P Global’s Miriam Fernández** In the rapidly evolving landscape...

**Exploring the Collaborative Opportunities Between AI and Synthetic Biology: An Interview with Miriam Fernández from S&P Global** In the rapidly...

**Exploring the Combined Impact of AI and Synthetic Biology: Insights from Miriam Fernández of S&P Global** In recent years, the...

**Exploring the Synergy Between AI and Synthetic Biology: Insights from Miriam Fernández of S&P Global** In recent years, the convergence...

# Exploring the Synergy Between AI and Synthetic Biology: Insights from S&P Global’s Miriam Fernández In recent years, the convergence...

**Exploring the Combined Impact of AI and Synthetic Biology: An Interview with Miriam Fernández from S&P Global** In the rapidly...

**Exploring the Synergistic Potential of AI and Synthetic Biology: Insights from S&P Global’s Miriam Fernández** In recent years, the convergence...

**Merck Announces Positive Results from Late-Stage Study of RSV Antibody** *October 2023* — Merck & Co., a global leader in...

**Merck Announces Successful Results from Late-Stage Study of RSV Antibody** In a significant stride towards combating respiratory syncytial virus (RSV),...

**Flu Shot Reduces Risk of Heart Attack, Study Finds** In a groundbreaking revelation, recent research has unveiled that the annual...

**Flu Shot May Lower Heart Attack Risk, Study Suggests** In recent years, the annual flu shot has been widely promoted...

**Flu Shot May Lower Risk of Heart Attack, Study Suggests** The annual flu shot is widely recognized as an essential...

**Flu Shot Linked to Lower Risk of Heart Attack, Study Finds** In a groundbreaking study that could reshape public health...

A study on the use of indigenously produced amylase from Bacillus cereus AS2 for eco-friendly textile desizing – Scientific Reports

Title: A Study on the Use of Indigenously Produced Amylase from Bacillus cereus AS2 for Eco-Friendly Textile Desizing

Introduction:

Textile desizing is an essential process in the textile industry, involving the removal of starch-based sizing agents from fabrics before further processing. Traditionally, this process has relied on the use of harsh chemicals, such as acids and alkalis, which can have detrimental effects on the environment and human health. In recent years, there has been a growing interest in developing eco-friendly alternatives for textile desizing. This article explores a study conducted on the use of indigenously produced amylase from Bacillus cereus AS2 as a sustainable solution for textile desizing.

Amylase and its Role in Textile Desizing:

Amylase is an enzyme that catalyzes the hydrolysis of starch into smaller, water-soluble molecules. In textile desizing, amylase breaks down the starch-based sizing agents applied to fabrics during the weaving process. This enzymatic desizing method offers several advantages over conventional chemical methods, including reduced energy consumption, shorter processing time, and minimal environmental impact.

The Study:

The study focused on the production and characterization of amylase from Bacillus cereus AS2, an indigenous strain isolated from local soil samples. The researchers optimized the fermentation conditions to maximize amylase production, including temperature, pH, and nutrient composition. The enzyme was then extracted and purified for further analysis.

The researchers evaluated the efficiency of the indigenously produced amylase in desizing cotton fabrics. They compared its performance with that of a commercially available amylase and a conventional chemical desizing agent. The desizing efficiency was assessed by measuring the percentage of starch removed from the fabric samples.

Results and Discussion:

The study found that the indigenously produced amylase from Bacillus cereus AS2 exhibited excellent desizing efficiency, comparable to the commercial amylase and chemical desizing agent. The enzyme effectively removed starch-based sizing agents from cotton fabrics, resulting in clean and ready-to-process textiles.

Furthermore, the researchers investigated the eco-friendliness of the indigenously produced amylase. They assessed its biodegradability, toxicity, and potential for wastewater treatment. The results indicated that the amylase was biodegradable, non-toxic, and could potentially be used for wastewater treatment, further highlighting its eco-friendly nature.

Conclusion:

The study demonstrates the potential of indigenously produced amylase from Bacillus cereus AS2 as an eco-friendly alternative for textile desizing. The enzyme exhibited comparable desizing efficiency to conventional chemical methods while offering significant environmental benefits. By replacing harsh chemicals with enzymatic desizing, the textile industry can reduce its ecological footprint and contribute to sustainable manufacturing practices. Further research and development in this area can lead to the widespread adoption of enzymatic desizing methods, promoting a greener and more sustainable textile industry.